Tongyuan Lin

Identification of novel and selective non-peptide inhibitors targeting the polo-box domain of polo-like kinase 1.

Huiyong Sun, Cheng Jiang, Yanhong Chen, 2018, Bioorganic chemistry.

Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.

Bin Di, Cheng Jiang, Tongyuan Lin, 2018, Bioorganic & medicinal chemistry.

Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer

Z. Yi, Shiyi Lv, Tongyuan Lin, 2023, Frontiers in Oncology.